Jonathan Noble

1.1k total citations
6 papers, 843 citations indexed

About

Jonathan Noble is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Jonathan Noble has authored 6 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Jonathan Noble's work include Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Angiogenesis and VEGF in Cancer (1 paper). Jonathan Noble is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Angiogenesis and VEGF in Cancer (1 paper). Jonathan Noble collaborates with scholars based in Canada and United States. Jonathan Noble's co-authors include Frances A. Shepherd, James L. Manley, Mauro Zukin, Francis Laberge, David Fenton, Lesley Seymour, Carol Prives, Zhen‐Qiang Pan, Glenwood Goss and Keyue Ding and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Jonathan Noble

6 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Noble Canada	6	566	500	249	107	48	6	843
J. Michel Belgium	15	504 0.9×	662 1.3×	217 0.9×	66 0.6×	42 0.9×	24	903
Johann Raats South Africa	9	280 0.5×	367 0.7×	188 0.8×	83 0.8×	101 2.1×	15	569
Frédéric Vallot Belgium	7	268 0.5×	359 0.7×	251 1.0×	109 1.0×	27 0.6×	18	613
Giovanni Palazzolo Italy	15	474 0.8×	528 1.1×	211 0.8×	85 0.8×	41 0.9×	47	786
Joan Lucca United States	12	753 1.3×	683 1.4×	196 0.8×	62 0.6×	48 1.0×	25	1.0k
R Gray United States	10	272 0.5×	445 0.9×	186 0.7×	313 2.9×	85 1.8×	15	732
Masahiro Morise Japan	17	752 1.3×	707 1.4×	206 0.8×	141 1.3×	50 1.0×	112	1.1k
J‐M Verdebout Belgium	10	413 0.7×	430 0.9×	316 1.3×	125 1.2×	25 0.5×	11	792
W. Franklin United States	14	456 0.8×	298 0.6×	321 1.3×	224 2.1×	44 0.9×	28	868
Jamie McIntosh United Kingdom	7	303 0.5×	325 0.7×	209 0.8×	151 1.4×	65 1.4×	12	599

Countries citing papers authored by Jonathan Noble

Since Specialization

Citations

This map shows the geographic impact of Jonathan Noble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Noble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Noble more than expected).

Fields of papers citing papers by Jonathan Noble

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Noble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Noble. The network helps show where Jonathan Noble may publish in the future.

Co-authorship network of co-authors of Jonathan Noble

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Noble. A scholar is included among the top collaborators of Jonathan Noble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Noble. Jonathan Noble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Goss, Glenwood, Chris J. O’Callaghan, Ian Lorimer, et al.. (2013). Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study. Journal of Clinical Oncology. 31(27). 3320–3326. 234 indexed citations

2.

Goss, Glenwood, Andrew Arnold, Frances A. Shepherd, et al.. (2009). Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study. Journal of Clinical Oncology. 28(1). 49–55. 186 indexed citations

3.

Bezjak, Andrea, Dongsheng Tu, Lesley Seymour, et al.. (2006). Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. Journal of Clinical Oncology. 24(24). 3831–3837. 239 indexed citations

4.

Noble, Jonathan, et al.. (2006). Phase II Clinical Trial Results Involving Treatment with Low-Dose Daily Oral Cyclophosphamide, Weekly Vinblastine, and Rofecoxib in Patients with Advanced Solid Tumors. Clinical Cancer Research. 12(10). 3092–3098. 89 indexed citations

5.

Noble, Jonathan, et al.. (1989). Factor Interactions with the Simian Virus 40 Early Pre-mRNA Influence Branch Site Selection and Alternative Splicing. Molecular and Cellular Biology. 9(5). 2007–2017. 9 indexed citations

6.

Noble, Jonathan, Zhen‐Qiang Pan, Carol Prives, & James L. Manley. (1987). Splicing of SV40 early pre-mRNA to large T and small t mRNAs utilizes different patterns of lariat branch sites. Cell. 50(2). 227–236. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact